The impact of different chelating leaving groups on the substitution kinetics of mononuclear PtII(1,2-trans-R,R-diaminocyclohexane)(X-Y) complexes

Journal of Biological Inorganic Chemistry

Volumn 12, Issue 4, 2007, Pages 461-475

  Summa, Nadine ^a   Soldatović, Tanja ^b   Dahlenburg, Lutz ^a   Bugarčić, Živadin D ^b   Van Eldik, Rudi ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF KRAGUJEVAC   (Serbia)

Author keywords

1,2 trans R,R Diaminocyclohexane; Guanosine 5 monophosphate; Kinetics; L Methionine; Platinum

Indexed keywords

CYCLOHEXANE DERIVATIVE; GLUTATHIONE; GLYCINE DERIVATIVE; GUANOSINE PHOSPHATE; METHIONINE DERIVATIVE; OXALIPLATIN; OXALIPLATIN DERIVATIVE; PLATINUM DERIVATIVE; THIOUREA; UNCLASSIFIED DRUG;

ARTICLE; CHELATION; COMPLEX FORMATION; CRYSTAL STRUCTURE; DRUG SYNTHESIS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SUBSTITUTION REACTION; ULTRAVIOLET SPECTROPHOTOMETRY; X RAY DIFFRACTION;

5'-GUANYLIC ACID; AMINO ACIDS; CHELATING AGENTS; CRYSTALLOGRAPHY, X-RAY; CYCLOHEXYLAMINES; GLUTATHIONE; KINETICS; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PLATINUM COMPOUNDS; THIOUREA;

EID: 34247569954     PISSN: 09498257     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00775-006-0200-z     Document Type: Article

References (42)

1. Lippert B (1999) In: Cisplatin: chemistry and biochemistry of a leading anticancer drug. Wiley-VCH, Zurich
2. Jamieson ER, Lippard SJ (1999) Chem Rev 99:2467-2498
3. Jakubec MA, Galanski M, Keppler BK (2003) Rev Physiol Biochem Pharmacol 146:1-53
4. Wong E, Giandomenico CM (1999) Chem Rev 99:2451-2466
5. Esposito BP, Najjar R (2002) Coord Chem Rev 232:137
6. Lenz G, Hacker UT, Kern W, Schalhorn A, Hiddemann W (2003) Anti-Cancer Drugs 14:731-733
7. Evans BD, Raju KS, Calvert AH, Harland SJ, Wiltshaw E (1983) Cancer Treat Rep 67:997-1000
8. Reedijk J (1999) Chem Rev 99:2499-2510
9. Summa N, Schiessl W, Puchta R, van Eikema Hommes N, van Eldik R (2006) Inorg Chem 45:2948-2959
10. Soldatovic T, Bugarcic ZD (2005) J Inorg Biochem 99:1472-1479
11. Bugarcic ZD, Heinemann FW, van Eldik R (2004) Dalton Trans 279-286
12. Bugarcic ZD, Liehr G, van Eldik R (2002) J Chem Soc Dalton Trans 2825-2830
13. Dorr RT (1996) In: Platinum and other metal coordination compounds in cancer chemotherapy. Plenum, New York
14. Teuben J-M, Reedijk J (2000) J Biol Inorg Chem 5:463-468
15. Fakih S, Munk VP, Shipman MA, Murdoch PdS, Parkinson JA, Sadler PJ (2003) Eur J Inorg Chem 1206-1214
16. Ghezzi A, Aceto M, Cassino C, Gabano E, Osella D (2004) J Inorg Biochem 98:73-78
17. Di Francesco AM, Ruggiero A, Riccardi R (2002) Cell Mol Life Sci 59:1914-1927
18. Woynarowska BA, Woynarowski JM (2002) Biochim Biophys Acta 1587:309-317
19. Stordal BK, Davey MW, Davey RA (2006) Cancer Chemother Pharmacol 58:256-265
20. Howell BA, Rashidianfar R, Glass JR, Hutchinson BJ, Johnson DA (1988) Inorg Chim Acta 142:181-183
21. Walker N, Stuart S (1983) Acta Crystallogr Sect A 39:158-166
22. Farrugia LJ (1999) J Appl Crystallogr 32:837
23. Altomare A, Burla MC, Camalli M, Cascarano GL, Giacovazzo A, Guagliardi AGG, Moliterni G, Polidori R, Spagna J (1999) J Appl Chrystallogr 32:115
24. Sheldrick GM (1998) Program for the refinement of crystal structures (release 97-2). Universität Göttingen
25. Farrugia LJ (1997) J Appl Crystallogr 30:565
26. Flack HD (1983) Acta Crystallogr Sect A 39:876-881
27. Mikkelsen K, Nielsen SO (1960) J Phys Chem 64:632-637
28. Frey U, Ranford JD, Sadler PJ (1993) Inorg Chem 32:1333-1340
29. Iakovidis A, Hadjiliadis N, Schöllhorm H, Thewalt U, Trötscher G (1989) Inorg Chim Acta 164:221-229
30. Bruck MA, Bau R, Noji M, Inagaki K, Kidani Y (1984) Inorg Chim Acta 91:279-284
31. Khokhar AR, Xu Q, Al-Baker S, Bear JL (1992) Inorg Chim Acta 194:243-246
32. Prenzler PD, McFadyen WD (1997) J Inorg Biochem 68:279-282
33. Cohn EJ, Edsall JT (1943) In: Proteins, amino acids and peptides as ions and dipolar ions. Reinhold, New York
34. Lide DR (1995) In: Handbook of chemistry and physics. CRC, New York
35. Connors KA (1990) In: Chemical kinetics, the study of reaction rates in solution. VCH, Weinheim
36. Appleton TG, Connor JW, Hall JR (1988) Inorg Chem 27:130-137
37. Vogel AI (1929) J Chem Soc 1487-1494
38. Hagrman D, Goodisman J, Souid A-K (2004) J Pharmacol Exp Ther 308:658-666
39. Barnham KJ, Djuran MI, Murdoch PdS, Ranford JD, Sadler PJ (1996) Inorg Chem 35:1065-1072
40. Goodisman J, Hagrman D, Tacka KA, Souid AK (2006) Cancer Chemother Pharmacol 57:257
41. Canovese L, Cattalini L, Chessa G, Tobe ML (1988) J Chem Soc Dalton Trans 2135-2140
42. Tobe ML, Burgess J (1999) In: Inorganic reaction mechanisms. Addison Wesley Longman, Harlow